A broad spectrum of concomitant disorders may complicate heart failure adding further morbidity and mortality risk. Comorbidities may be subdivided into cardiovascular and noncardiovascular. The first group includes hypertension, coronary artery disease, peripheral artery disease, cerebrovascular disease, arrhythmias and valvular heart disease. Noncardiovascular comorbidities include respiratory, endocrine, metabolic, nutritional, renal, hematopoietic, neurological as well as musculoskeletal conditions. In recent years, advances in the treatment of heart failure have not been attended by important changes in management of its comorbidities. They now seem to be major causes of the poor prognosis of heart failure patients. In this review we provide an updated summary of the epidemiological, pathophysiological and clinical characteristics of comorbidities as well as their potential impact for heart failure treatment.
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure / M. Metra, V. Zacà, G. Parati, P. Agostoni, M. Bonadies, M. Ciccone, A.D. Cas, M. Iacoviello, R. Lagioia, C. Lombardi, R. Maio, D. Magrì, G. Musca, M. Padeletti, F. Perticone, N. Pezzali, M. Piepoli, A. Sciacqua, L. Zanolla, S. Nodari, P.P. Filardi, L. Dei Cas, Heart Failure Study Group of the Italian Society of Cardiology. - In: JOURNAL OF CARDIOVASCULAR MEDICINE. - ISSN 1558-2027. - 12:2(2011 Feb), pp. 76-84. [10.2459/JCM.0b013e32834058d1]
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure
P. Agostoni;M. Piepoli;
2011
Abstract
A broad spectrum of concomitant disorders may complicate heart failure adding further morbidity and mortality risk. Comorbidities may be subdivided into cardiovascular and noncardiovascular. The first group includes hypertension, coronary artery disease, peripheral artery disease, cerebrovascular disease, arrhythmias and valvular heart disease. Noncardiovascular comorbidities include respiratory, endocrine, metabolic, nutritional, renal, hematopoietic, neurological as well as musculoskeletal conditions. In recent years, advances in the treatment of heart failure have not been attended by important changes in management of its comorbidities. They now seem to be major causes of the poor prognosis of heart failure patients. In this review we provide an updated summary of the epidemiological, pathophysiological and clinical characteristics of comorbidities as well as their potential impact for heart failure treatment.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
